JP2021097671A5 - - Google Patents

Download PDF

Info

Publication number
JP2021097671A5
JP2021097671A5 JP2021015026A JP2021015026A JP2021097671A5 JP 2021097671 A5 JP2021097671 A5 JP 2021097671A5 JP 2021015026 A JP2021015026 A JP 2021015026A JP 2021015026 A JP2021015026 A JP 2021015026A JP 2021097671 A5 JP2021097671 A5 JP 2021097671A5
Authority
JP
Japan
Prior art keywords
nucleic acid
seq
nos
sequences
intergenic region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021015026A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021097671A (ja
Filing date
Publication date
Priority claimed from JP2017093388A external-priority patent/JP6867866B2/ja
Application filed filed Critical
Publication of JP2021097671A publication Critical patent/JP2021097671A/ja
Publication of JP2021097671A5 publication Critical patent/JP2021097671A5/ja
Pending legal-status Critical Current

Links

JP2021015026A 2011-06-01 2021-02-02 細菌のポリシストロン性発現系 Pending JP2021097671A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11168495.7 2011-06-01
EP11168495 2011-06-01
EP11173588 2011-07-12
EP11173588.2 2011-07-12
JP2017093388A JP6867866B2 (ja) 2011-06-01 2017-05-09 細菌のポリシストロン性発現系

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017093388A Division JP6867866B2 (ja) 2011-06-01 2017-05-09 細菌のポリシストロン性発現系

Publications (2)

Publication Number Publication Date
JP2021097671A JP2021097671A (ja) 2021-07-01
JP2021097671A5 true JP2021097671A5 (cg-RX-API-DMAC10.html) 2021-08-12

Family

ID=46354175

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014513212A Expired - Fee Related JP6175428B2 (ja) 2011-06-01 2012-06-01 細菌のポリシストロン性発現系
JP2017093388A Active JP6867866B2 (ja) 2011-06-01 2017-05-09 細菌のポリシストロン性発現系
JP2021015026A Pending JP2021097671A (ja) 2011-06-01 2021-02-02 細菌のポリシストロン性発現系

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2014513212A Expired - Fee Related JP6175428B2 (ja) 2011-06-01 2012-06-01 細菌のポリシストロン性発現系
JP2017093388A Active JP6867866B2 (ja) 2011-06-01 2017-05-09 細菌のポリシストロン性発現系

Country Status (13)

Country Link
US (3) US9920324B2 (cg-RX-API-DMAC10.html)
EP (2) EP2714912B1 (cg-RX-API-DMAC10.html)
JP (3) JP6175428B2 (cg-RX-API-DMAC10.html)
KR (1) KR102066292B1 (cg-RX-API-DMAC10.html)
CN (2) CN103562390B (cg-RX-API-DMAC10.html)
AU (2) AU2012264589B2 (cg-RX-API-DMAC10.html)
BR (1) BR112013030824A8 (cg-RX-API-DMAC10.html)
CA (2) CA2837634C (cg-RX-API-DMAC10.html)
DK (1) DK2714912T3 (cg-RX-API-DMAC10.html)
ES (1) ES2676877T3 (cg-RX-API-DMAC10.html)
HU (1) HUE039577T2 (cg-RX-API-DMAC10.html)
RU (2) RU2644346C2 (cg-RX-API-DMAC10.html)
WO (1) WO2012164083A1 (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2714912B1 (en) 2011-06-01 2018-05-02 Intrexon Actobiotics NV Polycistronic expression system for bacteria
US9593339B1 (en) * 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
EP3034610A1 (en) * 2013-08-13 2016-06-22 The Kitasato Institute Novel terpenoid compound and method for producing same
ES2884948T3 (es) 2014-12-03 2021-12-13 Azusapharma Sciences Inc Plásmido de coexpresión
EP3237622B1 (en) 2014-12-23 2021-02-24 Ilya Pharma AB Methods for wound healing
AU2016261279B2 (en) 2015-05-10 2020-12-10 Ventana Medical Systems, Inc. Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during automated multiplex tissue staining assays
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
JP7292877B2 (ja) 2016-01-14 2023-06-19 イントレクソン・アクトバイオテイクス・エヌブイ 1型糖尿病を処置するための組成物および方法
US10858663B2 (en) 2016-09-02 2020-12-08 Intrexon Actobiotics N.V. Genetically modified bacteria stably expressing IL-10 and insulin
KR102469701B1 (ko) * 2016-09-13 2022-11-22 인트랙슨 액토바이오틱스 엔.브이. 점막부착성 미생물
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
GB201906775D0 (en) * 2019-05-14 2019-06-26 Res & Innovation Uk Synthetic genome
CA3156035A1 (en) 2019-09-27 2021-04-01 Intrexon Actobiotics Nv D/B/A Precigen Actobio Treatment of celiac disease
WO2024003873A1 (en) 2022-06-30 2024-01-04 Intrexon Actobiotics Nv D/B/A Precigen Actobio Single variable domain antibodies against tumor necrosis factor-alpha

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB227835A (en) 1924-01-15 1925-04-09 Harry Odell Improvements in feeding mechanism for embossing and other printing presses
JPS58116498A (ja) 1981-12-28 1983-07-11 Takeda Chem Ind Ltd Il‐2をコードする新規伝令rnaの製造法
EP0091539B2 (en) 1982-03-31 1996-11-27 Ajinomoto Co., Inc. Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4752585A (en) 1985-12-17 1988-06-21 Cetus Corporation Oxidation-resistant muteins
JPH01196296A (ja) * 1988-01-29 1989-08-08 Toray Ind Inc 動物細胞用発現ベクター
US4919918A (en) 1988-03-14 1990-04-24 Spectrum Consumer Products Co., Inc. Non-alcoholic mouthwash
US5972685A (en) 1988-07-21 1999-10-26 Iowa State University Research Foundation, Inc. Oral administration of coprostanol producing microorganisms to humans to decrease plasma cholesterol concentration
GB9006400D0 (en) 1990-03-22 1990-05-23 Ciba Geigy Ag Bacterial vectors
WO1992014837A1 (en) 1991-02-14 1992-09-03 The General Hospital Corporation Intestinal trefoil proteins
US6221840B1 (en) 1991-02-14 2001-04-24 The General Hospital Corporation Intestinal trefoil proteins
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
GB9126306D0 (en) 1991-12-11 1992-02-12 Unilever Plc Mouthwash compositions
EP0628083A1 (en) 1992-02-27 1994-12-14 Microbial Technics Limited Heterologous gene expression in lactococcus, and the expression products therefrom
US5223285A (en) 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
EP0569604A1 (en) 1992-04-07 1993-11-18 Societe Des Produits Nestle S.A. Integrative gene-expression in Streptococcus salivarius ssp.thermophilus
US5229109A (en) 1992-04-14 1993-07-20 Board Of Regents, The University Of Texas System Low toxicity interleukin-2 analogues for use in immunotherapy
US5700782A (en) 1993-05-28 1997-12-23 Abbott Laboratories Enteral nutritional product
WO1996032486A1 (en) 1995-04-11 1996-10-17 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface
US5695746A (en) 1995-07-28 1997-12-09 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Liquid dentifrice with mouthwash fresh taste
GB9521568D0 (en) 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
US6348187B1 (en) 1996-01-24 2002-02-19 Warner-Lambert Company Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems
GB9611364D0 (en) 1996-05-31 1996-08-07 Smithkline Beecham Plc Composition
ES2197364T3 (es) 1996-09-18 2004-01-01 Erling Johansen Baño bucal comprendiendo iones de calcio y fosfato en solucion sobresaturada.
US5869118A (en) 1996-11-13 1999-02-09 Abbott Laboratories Gellan gum to improve physical stability of liquid nutritional products
US6171611B1 (en) 1997-11-12 2001-01-09 Dante J. Picciano Iodine-containing nasal moisturizing saline and mouthwash solutions
US5897872A (en) 1997-11-12 1999-04-27 Picciano; Dante J. Iodine-containing nasal moisturizing saline solution
WO2000018377A1 (en) 1998-09-28 2000-04-06 Warner-Lambert Company Enteric and colonic delivery using hpmc capsules
WO2000022909A2 (en) 1998-10-19 2000-04-27 Biotech Australia Pty. Limited Systems for oral delivery
EP1123314B1 (en) 1998-10-20 2004-02-18 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Use of a cytokine-producing lactococcus strain to treat colitis
CA2378143A1 (en) 1999-06-30 2001-01-11 Societe Des Produits Nestle S.A. The lactose operon of lactobacillus delbrueckii and its use for controlling gene transcription and/or expression in bacterial cells
ES2272311T3 (es) 1999-07-05 2007-05-01 Vlaams Interuniversitair Instituut Voor Biotechnologie Suministro de peptidos trebol.
AU2001238582A1 (en) * 2000-02-24 2001-09-03 Siga Pharmaceuticals, Inc Intergenic and intragenic integration sites for foreign gene expression in recombinant s. gordonii strains
US7029842B2 (en) * 2000-04-07 2006-04-18 Novozymes A/S Signal sequence trapping
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
CA2446776C (en) 2001-05-03 2011-07-12 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Self-containing lactococcus strain
EP1319410A1 (en) * 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Use of micro-organisms for a directed delivery of substances to specific parts of the gut
AU2003247881A1 (en) 2002-07-08 2004-01-23 Joe S. Wilkins Jr. Antibacterial formulations
AU2003298291A1 (en) 2002-11-15 2004-06-15 Universiteit Gent Self-containing lactobacillus strain
WO2004069177A2 (en) 2003-01-31 2004-08-19 The Trustees Of The University Of Pennsylvania Methods for modulating an inflammatory response
EP1493816A1 (en) * 2003-07-02 2005-01-05 Friesland Brands B.V. Methods and means for regulating gene expression
WO2005007121A2 (en) 2003-07-18 2005-01-27 Massachusetts Institute Of Technology Mutant interleukin-2(il-2) polypeptides
CA2551644C (en) 2003-12-24 2014-03-04 Cerus Corporation Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of usethereof
US7842289B2 (en) * 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
KR20070003934A (ko) 2004-03-05 2007-01-05 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 치료제의 환자 내약성을 예측하기 위한 시험관 내 테스트시스템
US7495092B2 (en) * 2005-01-14 2009-02-24 North Carolina State University Compositions comprising promoter sequences and methods of use
US7764366B2 (en) 2006-07-11 2010-07-27 Besi North America, Inc. Robotic die sorter with optical inspection system
JP2009544679A (ja) * 2006-07-25 2009-12-17 ザ ユニヴァーシティー コート オブ ザ ユニヴァーシティー オブ ダンディー 異常な細胞増殖に関連する疾患の治療におけるレチノイド及び小分子のNrf2アンタゴニストとしての使用
CN101605900B (zh) * 2007-01-12 2014-04-23 阿克图杰尼斯公司 乳球菌启动子和其用途
ES2425385T3 (es) 2009-04-30 2013-10-15 Actogenix N.V. Crioprotectores para la liofilización de las bacterias de ácido láctico
CN105440123B (zh) 2011-02-10 2020-10-09 罗切格利卡特公司 突变体白介素-2多肽
US9669071B2 (en) 2011-03-11 2017-06-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for stimulating T lymphocytes with IL-2
EP2714912B1 (en) 2011-06-01 2018-05-02 Intrexon Actobiotics NV Polycistronic expression system for bacteria
EP2753362A4 (en) 2011-09-08 2015-04-15 Univ Florida MATERIALS AND METHOD FOR MODULATING IMMUNE SYSTEM REACTIONS
JP7292877B2 (ja) 2016-01-14 2023-06-19 イントレクソン・アクトバイオテイクス・エヌブイ 1型糖尿病を処置するための組成物および方法

Similar Documents

Publication Publication Date Title
CN112501102B (zh) 一株高效生产四氢嘧啶的大肠杆菌重组菌
JP2024535672A5 (cg-RX-API-DMAC10.html)
JP2023519953A5 (cg-RX-API-DMAC10.html)
JP2020518276A5 (cg-RX-API-DMAC10.html)
JP2020506667A5 (cg-RX-API-DMAC10.html)
JP2018521630A5 (cg-RX-API-DMAC10.html)
JP2010187673A5 (cg-RX-API-DMAC10.html)
JP2012528572A5 (cg-RX-API-DMAC10.html)
JP2013530689A5 (cg-RX-API-DMAC10.html)
CN108277231B (zh) 一种用于棒状杆菌基因组编辑的crispr系统
JP2015517803A5 (cg-RX-API-DMAC10.html)
NZ592082A (en) Promoters for recombinant viral expression
CN115551879A (zh) Drw1蛋白调控水稻株高和种子大小的应用
JP7481755B2 (ja) 組換えパルボウイルスベクターならびにその作製および使用方法
JP6748074B2 (ja) バクテリオファージの改変
JP2025505732A5 (cg-RX-API-DMAC10.html)
Nishigawa et al. Evidence of intermolecular recombination between extrachromosomal DNAs in phytoplasma: a trigger for the biological diversity of phytoplasma?
JP2010532979A5 (cg-RX-API-DMAC10.html)
JP2005509420A5 (cg-RX-API-DMAC10.html)
JP2021522825A5 (cg-RX-API-DMAC10.html)
CN104388456A (zh) 一种同时表达两条sgRNA的载体的构建方法
WO2022159742A1 (en) Novel engineered and chimeric nucleases
JPWO2022196245A5 (cg-RX-API-DMAC10.html)
KR100578395B1 (ko) 면역기능이 강화된 사균화 유산균 제제 및 그 제조방법
JP4465741B2 (ja) 二本鎖dna断片の末端での連結